相关实验视频

Updated: Feb 28, 2026

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

在人类鼻腔呼吸道上皮细胞中恢复缺陷的CFTR,通过CFTR调节器和mRNA传染

Roshani Narayan Singh¹, Marilia Marta Horn², Marin Juko¹

¹Department of General Paediatrics, University Hospital Muenster, Albert-Schweitzer-Campus 1, 48149 Muenster, Germany.

International journal of molecular sciences

|February 27, 2026

概括

基托桑介导的CFTRmRNA输送成功地恢复了患有罕见CFTR变异型不响应调制剂治疗的患者的囊性纤维化 (CF) 气道培养中的功能,为有效的CF治疗提供了新的希望.

科学领域:

生物医学工程生物医学工程
基因治疗基因治疗
呼吸系统医学呼吸系统医学

背景情况:

囊性纤维化 (CF) 是由CFTR基因变异引起的,导致离子运输受损和厚液.
目前的CFTR调节器对许多,但并非所有CF患者都有效,特别是那些患有罕见变异的人.
对于CF患者来说,对现有疗法反应有限或不反应的替代疗法非常需要.

研究的目的:

评估基托介导的CFTRmRNA输送作为CF的治疗策略.
评估CFTR恢复在患有罕见CFTR变异的患者衍生气道培养中的有效性.
为了比较mRNA输送与现有调节器疗法的有效性.

主要方法:

使用了21名CF患者和21名健康对照组的初级空气液界面 (ALI) 气道培养物.
基托桑介导的CFTR mRNA传递和CFTR调节器被应用到培养物中.
电生理学 (多晶体状体电流使用室) 和免疫光染色被用于评估.

主要成果:

在大多数CF培养物中,CFTR调节器改善了功能,但在具有I类或罕见变异的培养物中没有改善.
基托桑介导的CFTRmRNA输送成功地恢复了罕见变异的培养物中的CFTR功能.
治疗降低了CF培养物中MUC5AC表达率和粘液粘度的升高,接近健康的对照水平.

结论:

素-CFTR mRNA输送显示了CF患者的显著治疗潜力,特别是那些对调节器无反应的患者.
这种方法为治疗由罕见遗传变异引起的CF提供了可行的替代方案.
来自患者的呼吸道模型为评估基于mRNA的新疗法提供了一个有价值的平台.

关键词:

使用室使用室.囊性纤维化症是什么免疫光效应免疫光效应在mRNA治疗过程中.模块化器是一个模块化器.粘液粘度粘液粘度粘液粘度

更多相关视频

Primary Human Nasal Epithelial Cells: Biobanking in the Context of Precision Medicine

Primary Human Nasal Epithelial Cells: Biobanking in the Context of Precision Medicine

Published on: April 22, 2022

Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae

Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae

Published on: May 10, 2014

相关概念视频

Cystic Fibrosis: Management

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...

Cystic Fibrosis: Pathogenesis

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...